Pharma
At Health 2.0 Europe, pharma, patient and academic representatives weighed in on challenges of working together.
The blockchain-enabled startup's new pilot will rely on its database of sequenced genomes.
At BIO 2019, Sanofi's chief medical and digital officer advised fellow pharma leaders on embracing new technologies and preparing for the challenges they'll bring.
Cross-sector collaboration creates enormous potential for people-centred healthcare innovations, but there are challenges to be overcome.
Roche, J&J regulatory leads weigh in on Pre-Cert's progress, challenges of regulating digital health
At BIO 2019 in Philadelphia, a panel of industry experts discussed their experiences with the FDA's pilot program; ambiguities in drug, device and software pathways; and the hurdles digital health regulation has yet to properly address.
Quantuvis is bringing managed care and pharmaceutical companies together to get the most effective drugs at the lowest prices to patients, says CEO Lisa Bair.
The pair plans to use MC10's FDA-cleared wearable sensors, called BioStamp nPoint, to get insights into a patient's physiological data during the studies.
Pharma companies are entering the “drug and digital” era, where they need to provide digital solutions to deliver more value to patients, says veteran healthcare leader and Health Innovation Strategies CEO Naomi Fried.
This morning MassBio hosted a panel on the use cases for the technology in clinical trials and beyond.
The Singaporean company will be moving its headquarters to Boston.